Prostasin and hepatocyte growth factor B in factor VIIa generation: Serine protease knockdowns in zebrafish
Abstract Background Blood clotting in humans is initiated by the binding of tissue factor to activated coagulation factor VII (FVIIa) in the plasma. Previous studies have reported that hepsin and factor VII (FVII)‐activating protease are responsible for generating FVIIa. Objectives We aimed to ident...
Main Authors: | Gauri Khandekar, Neha Iyer, Pudur Jagadeeswaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12428 |
Similar Items
-
Low-dose recombinant factor VIIa for massive bleeding
by: A Mordasini, et al.
Published: (2011-07-01) -
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety
by: Johnny Mahlangu, et al.
Published: (2021-08-01) -
Anesthetic management of a patient with factor VII deficiency undergoing laparoscopic colectomy: a case report
by: Akari Yoshida, et al.
Published: (2016-10-01) -
Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury
by: Bobby Kim, et al.
Published: (2014-01-01) -
Knockdown of myorg leads to brain calcification in zebrafish
by: Miao Zhao, et al.
Published: (2022-07-01)